Weight-loss drugs show signs of slowing biological aging, say drugmakers
Weight-loss drugs show signs of slowing biological aging, say drugmakers
摘要: Biotechnology and health
Weight-loss drugs show signs of slowing biological aging, say drugmakers
Novo Nordisk and Eli Lilly found the popular medic
正文
Biotechnology and health
Weight-loss drugs show signs of slowing biological aging, say drugmakers
Novo Nordisk and Eli Lilly found the popular medicines reduce molecular markers of age.
Antonio Regalado
archive page
October 6, 2026
Stephanie Arnett/ MIT Technology Review | Adobe Stock
Popular weight-loss drugs may do more than help people shed pounds. They might also melt away the years.
Drug giants Eli Lilly and Novo Nordisk say patients taking their drugs age less quickly, according to readouts from molecular “aging clocks.”
Such clocks assess a person’s biological age by looking at changes to DNA that accumulate with time, or, in newer versions, by tracking levels of key proteins.
Both companies found that overweight or diabetic patients taking the drugs, called GLP-1s, had reduced biological age compared to those taking a placebo, although the difference varied widely, depending on which type of clock was used, and what organ was tested.
Overall, the difference was around “two to three years,” according to Nikolaj Roed, a global project leader at Novo, who says the company has been seeing “improved biological age in our patients across trials and across different tissues.”
The findings add to wide speculation among scientists that GLP-1 drugs, as they are known, are acting on basic causes of aging and might be a true longevity treatment.
“Two years is a pretty strong effect, in my book,” says Steve Horvath, a professor at the University of California, Los Angeles, who’s credited with
inventing aging clocks
.
Horvath says the emerging data could provide “evidence that these GLP-1 drugs are actually what is known as geroprotectors, medications that slow or possibly even reverse biologic aging.”
The companies shared their findings over the weekend during Aging Research & Drug Discovery, a conference devoted to seeking scientific remedies for old age. While that quest has not yet produced any clear-cut success, some scientists now think Novo’s d